SCHEMBL14768692

SCHEMBL14768692

CCCC(=O)N1CCN(c2cnccn2)CC1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A7 Q99884 1/20 0.51
POLB P06746 1/20 0.51
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
KDM4E B2RXH2 2/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
HPGD P15428 1/20 0.49
RECQL P46063 1/20 0.49
HSD17B10 Q99714 1/20 0.49
DPP4 P27487 1/20 0.47
ALDH1A1 P00352 1/20 0.47
SORD Q00796 1/20 0.47
HRH3 Q9Y5N1 4/20 0.46
MAPT P10636 2/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
GPR119 Q8TDV5 1/20 0.46
ADORA2B P29275 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11090165 0.89 GNAI3 (0.49) SLC6A7POLBMEN1KMT2AKDM4E
SCHEMBL14224744 0.88 CKS1B (0.53) SLC6A7POLBMEN1KMT2AKDM4E
SCHEMBL14411664 0.84 SLC6A7 (0.54) SLC6A7MEN1KMT2AKDM4ECYP3A4
SCHEMBL22481434 0.82 SLC6A7 (0.53) SLC6A7POLBMEN1KMT2AKDM4E
SCHEMBL13073553 0.80 SLC6A7 (0.57) SLC6A7MEN1KMT2AKDM4EHPGD
SCHEMBL27723124 0.80 SLC6A7 (0.59) SLC6A7MEN1KMT2AKDM4EHPGD
SCHEMBL3710705 0.79 SLC6A7 (0.62) SLC6A7MEN1KMT2AKDM4ESORD
SCHEMBL29741845 0.78 HRH3 (0.53) SLC6A7POLBMEN1KMT2AKDM4E
SCHEMBL11079223 0.78 KDM4E (0.72) SLC6A7POLBMEN1KMT2AKDM4E
SCHEMBL3332171 0.77 HRH3 (0.58) POLBMEN1KMT2AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130064783-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2013-03-14 US disclosed
US-20130064783-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130064783-A1 BORON-CONTAINING SMALL MOLECULES ETF1, POLR1C, DPM1 SLC6A7 491/4885POLB 826/4885MEN1 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.